Aides in Respiration Health Coaching for COPD

Trial ID or NCT#

NCT02234284

Status

not recruiting iconNOT RECRUITING

Purpose

This study examined whether health coaches can improve the management of chronic obstructive pulmonary disease (COPD) in a population of vulnerable patients cared for in 'safety-net' clinics. The study is designed as a randomized controlled trial for patients with moderate to severe COPD. Patients were randomized into a health coaching group and a usual care group. Those in the health coaching group received 9 months of active health coaching. Outcome variables were measured at baseline and after 9 months

Official Title

Health Coaching to Reduce Disparities for Patients With Chronic Obstructive Pulmonary Disease (COPD)

Eligibility Criteria

Ages Eligible for Study: 40 Years to 95 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. - Patient at one of the participating primary care clinics (at least 1 visit in past 12 months) - Age 40 and older - Speaking English or Spanish - Plan to continue to be seen at current clinic and to not leave the area for >2 months anytime in the next 9 months or to be absent at 9 or 15 months - COPD defined as ever having had a post-bronchodilator Forced Expiratory Volume in 1 second/Forced Vital Capacity (FEV1/FVC) <.70 of FEV1/FVC of .70 to .74 and diagnosis of COPD by the study pulmonologist - Willingness to attempt spirometry - At least moderate COPD, defined as at least one of the following: - Ever Forced Expiratory Volume in 1 second (FEV1) < 80% predicted - 1 or more emergency department (ED) visit for COPD exacerbation in past 12 months - 1 or more hospital stays for COPD exacerbation in past 12 months - 1 or more prescriptions for oral prednisone for a COPD exacerbation in past 12 months - Ever on home oxygen therapy - Ever outpatient percutaneous oxygen saturation of /=10 OR an modified Medical Research Council (mMRC) score of >/=2). - Currently using tiotropium inhaler or combination inhaled corticosteroid and long-acting beta agonist
Exclusion Criteria:
  1. - Unable to participate in the study due to mental or physical impairment - Severe or terminal illness that precludes focus on COPD - No phone